Definitive Contract HDTRA119C0036
Award Date
7/22/19
Potential Completion Date
7/21/22
Potential Value
$4.4M
Federal Agency
Defense Threat Reduction Agency
Awardee
Ministry Of Defence
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to the Ministry of Defence (doing business as DSTL), a government entity in the United Kingdom, by the Defense Threat Reduction Agency (DTRA). The $824,565 cost-plus-fixed-fee contract supports chemical agent system testing. The work, which is not set aside, involves research and development services focused on countering chemical, biological, radiological, and nuclear threats. This includes developing medical countermeasures, diagnostic tools, conducting...
This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation. DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus...
The U.S. Defense Threat Reduction Agency awarded a $3,922,194.00 cost-plus-fixed-fee definitive contract to the Ministry of Defence, doing business as DSTL, located in the United Kingdom. The contract is for the CRYSTALCAST TOOLSET and has an ultimate completion date of August 24, 2021. The contract has no set-aside designation. Based on the agency and the nature of the work, this contract supports the Defense Threat Reduction Agency's efforts to counter chemical, biological, radiological, and...
This federal contract award, valued at $5,379,526.00, was issued by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The award is for a base period and does not have a set-aside designation. DSTL has an Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over seven years,...
This is a $523,200.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), located in the United Kingdom. The contract is for basic research to support DTRA and Department of Homeland Security efforts to counter chemical, biological, radiological, and nuclear threats. Past MOD contracts have included developing medical countermeasures, diagnostic...
This is a federal contract award to the Ministry of Defence (MOD), doing business as D S T L, located in Great Britain, United Kingdom. The contract, valued at $4,385,034.00, is a Delivery Order contract with a Cost Plus Fixed Fee pricing type, awarded by the Defense Threat Reduction Agency (DTRA) for "ANTHRAX DETECTION - BASE" efforts. The contract has no set-aside designation. Based on the vendor's past performance, the work likely involves research and development services focused...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract...
This is a $7,994,572.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract is for the generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague. This contract is not set aside. DSTL has secured multiple high-value federal contracts from DTRA...
This is a $1,189,718.74 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as DSTL, located in Great Britain, United Kingdom. The contract is for pharmacological and biologic interventions to reduce inflammation and seizures caused by viral encephalitis. This contract was awarded under a Broad Agency Announcement (BAA) from DTRA that sought proposals for various chemical and biological defense technology areas,...
This is a $3,947,011.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The contract is for a research and development effort focused on using virus-like particles as a novel platform for delivering protective antigens against Burkholderia bacteria. The contract does not have a set-aside designation. DSTL is a...